SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-24-004962
Filing Date
2024-07-19
Accepted
2024-07-19 17:12:54
Documents
16

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 cns_s1a1.htm   iXBRL S-1/A 404367
2 FORM OF SERIES F COMMON STOCK PURCHASE WARRANT cns_ex0417.htm EX-4.17 110355
3 FORM OF SERIES G COMMON STOCK PURCHASE WARRANT cns_ex0418.htm EX-4.18 110319
  Complete submission text file 0001683168-24-004962.txt   914120

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cnsp-20240719.xsd EX-101.SCH 3018
5 XBRL LABEL FILE cnsp-20240719_lab.xml EX-101.LAB 34767
6 XBRL PRESENTATION FILE cnsp-20240719_pre.xml EX-101.PRE 22719
19 EXTRACTED XBRL INSTANCE DOCUMENT cns_s1a1_htm.xml XML 3251
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-280074 | Film No.: 241128475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)